Treating to Target for Patients With Hypertension

• Sponsor: University of California, San Francisco (Other)
• Overall Status: Completed
• CT.gov ID: NCT01013857
• Collaborator: Kaiser Permanente (Other)
• Enrollment: 240
• Location: 1
• Arms: 2
• Duration (Months): 35
• Patients Per Site Per Month: 6.9

Study Details

Study Description

Brief Summary

Patients with poorly controlled hypertension will have improved hypertensive control with telephone coaching and with telephone coaching combined with home-titration of medications.

Condition or Disease	Intervention/Treatment	Phase
Hypertension	Behavioral: Health coaching; Behavioral: Health coaching plus home titration	N/A

Detailed Description

Patients with poorly controlled hypertension are randomized to a control arm which receives telephone coaching or an active arm which receives telephone coaching plus intensification of medications via telephone coaching with the coaches using treatment algorithms approved by the patients' physician. These patients' blood pressure control will be compared with usual care patients in a passive arm (chart review only).

Study Design

• Study Type: Interventional
• Actual Enrollment: 240 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Treating to Target for Patients With Hypertension
• Study Start Date: Jan 1, 2009
• Actual Primary Completion Date: Feb 1, 2010
• Actual Study Completion Date: Dec 1, 2011

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Health coaching Phone patients every week to discuss medication adherence	Behavioral: Health coaching; Calling patients every week to discuss medication adherence
Experimental: Health coaching plus home-titration Health coaches call patients every week to discuss medication adherence and to intensify medications if appropriate according to physician-created algorithm	Behavioral: Health coaching plus home titration; Calling patients every week and intensifying medications if appropriate based on physician-created algorithm

Outcome Measures

Primary Outcome Measures

1. Systolic blood pressure [6 months]

Secondary Outcome Measures

1. Diastolic blood pressure [6 months]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 30 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• 2 blood pressure readings above 145/90.

Exclusion Criteria:

• Cognitive impairment,

• Short life expectancy,

• Creatinine greater than 1.5,

• Inability to check blood pressures at home.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	San Francisco General Hospital	San Francisco	California	United States	94110

Sponsors and Collaborators

• University of California, San Francisco
• Kaiser Permanente

Investigators

• Principal Investigator: Thomas Bodenheimer, MD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University of California, San Francisco
• ClinicalTrials.gov Identifier: NCT01013857
• Other Study ID Numbers: H40013-33128-02
• First Posted: Nov 16, 2009
• Last Update Posted: Mar 21, 2022
• Last Verified: Mar 1, 2022

• Additional relevant MeSH terms: Hypertension

Study Results

No Results Posted as of Mar 21, 2022